Dark

ALC
Alcon Inc.
stock NYSE

Market Open

May 15, 2025 3:15:16 PM EDT

87.59USD+0.401%(+0.35)1,511,332

87.58Bid 87.63Ask 0.05Spread

Pre-market

May 15, 2025 9:27:30 AM EDT

88.10USD+0.986%(+0.86)1,470

After-hours

May 14, 2025 4:06:30 PM EDT

87.12USD-0.138%(-0.12)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 18, 2022

09:35AM EST Stephens & Co. Downgrades Alcon to Equal-Weight, Lowers Price Target to $86 Benzinga

Jan 12, 2022

01:04AM EST Alcon Announces Launch Of Systane Complete Preservative-Free Lubricant Eye Drops In Europe RTTNews

Jan 11, 2022

01:00AM EST Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism Business Wire

Jan 10, 2022

02:25AM EST Alcon Inc. (ALC), a global player in eye care, on Monday announced the closing of its previously announced acquisition of Ivantis, the developer of Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery. RTTNews

01:06AM EST Alcon Completes Acquisition Of Ivantis RTTNews

01:00AM EST Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio Business Wire

Jan 7, 2022

01:07PM EST Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 Benzinga

01:06PM EST Analyst Ratings For Alcon Benzinga

01:01PM EST Morgan Stanley Downgrades Alcon to Equal-Weight, Announces $95 Price Target Benzinga

Nov 12, 2021

08:26AM EST Credit Suisse Maintains Outperform on Alcon, Raises Price Target to $93 Benzinga

Nov 11, 2021

12:22PM EST Expert Ratings For Alcon Benzinga

10:05AM EST Citigroup Maintains Neutral on Alcon, Raises Price Target to $87 Benzinga

08:33AM EST Morgan Stanley Maintains Overweight on Alcon, Raises Price Target to $95 Benzinga

Nov 9, 2021

06:31PM EST Alcon Q3 EPS $0.54 Beats $0.49 Estimate, Sales $2.08B Beat $2.04B Estimate Benzinga

04:30PM EST Alcon Reports Third Quarter 2021 Results Business Wire

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 8, 2021

09:00AM EST Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021 Business Wire

06:11AM EST Alcon Strengthens Surgical Glaucoma Portfolio With $475M Ivantis Deal Benzinga

01:35AM EST Alcon (ALC), an American-Swiss medical company specializing in eye care products, said on Monday it will acquire Ivantis Inc., a developer and manufacturer of the novel Hydrus Microstent, a minimally-invasive glaucoma surgery or MIGS device, for an upfront consideration of $475 million. RTTNews

01:11AM EST Alcon To Pay $475 Mln In Upfront Consideration To Acquire Ivantis RTTNews

12:59AM EST Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio Business Wire

Nov 3, 2021

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Nov 1, 2021

03:23PM EDT Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs Business Wire

Oct 14, 2021

09:00AM EDT Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care Business Wire

Oct 1, 2021

12:47PM EDT Where Alcon Stands With Analysts Benzinga

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021 Benzinga

05:07AM EDT Oppenheimer Initiates Coverage On Alcon with Perform Rating Benzinga

Sep 27, 2021

10:58AM EDT Alcon Honored with FutureEdge 50 Award Business Wire

Sep 16, 2021

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

Sep 15, 2021

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

Sep 13, 2021

12:58PM EDT Where Alcon Stands With Analysts Benzinga

07:37AM EDT Wells Fargo Maintains Overweight on Alcon, Raises Price Target to $93 Benzinga

Aug 19, 2021

08:23AM EDT BTIG Maintains Buy on Alcon, Raises Price Target to $84 Benzinga

07:51AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

07:30AM EDT Credit Suisse Maintains Outperform on Alcon, Raises Price Target to $90 Benzinga

07:30AM EDT Wells Fargo Maintains Overweight on Alcon, Raises Price Target to $90 Benzinga

04:46AM EDT SVB Leerink Maintains Market Perform on Alcon, Raises Price Target to $82 Benzinga

Aug 18, 2021

02:30PM EDT Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet Benzinga

12:09PM EDT Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide Benzinga

11:09AM EDT Alcon Shares Up 11% As Q2 Profit Beats Street View RTTNews

07:51AM EDT Geneva based eye care company Alcon Inc. (ALC) is trending 10 percent higher in pre-market trade after second quarter results topped top-line and bottom-line estimates and full year guidance was raised above view. RTTNews

06:10AM EDT A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Fed Minutes Benzinga

05:57AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT). RTTNews

Aug 17, 2021

04:33PM EDT UPDATE: Alcon Raises FY21 Sales Guidance From $7.8B-$8B to $8B-$8.2B vs $7.92B Estimate, Core EPS From $1.85-$1.95 To $2-$2.10 vs $1.93 Est. Benzinga

04:32PM EDT Alcon Q2 Core EPS $0.56 Beats $0.45 Estimate, Sales $2.09B Beat $1.96B Estimate; Raises Guidance Benzinga

04:30PM EDT Alcon Reports Second Quarter 2021 Results Business Wire

08:03AM EDT Earnings Scheduled For August 17, 2021 Benzinga

Aug 11, 2021

01:00AM EDT Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens Business Wire

Aug 5, 2021

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Jul 22, 2021

04:35PM EDT Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021 Business Wire

Jun 28, 2021

12:00PM EDT Alcon Announces Executive Committee Changes Business Wire

Jun 9, 2021

04:01PM EDT Arcutis Announces Appointment of Sue-Jean Lin to Board of Directors GlobeNewswire Inc

Jun 7, 2021

04:45PM EDT Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021 Business Wire

May 18, 2021

12:16PM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021 Benzinga

May 6, 2021

07:28AM EDT Citigroup Upgrades Alcon to Neutral, Raises Price Target to $72 Benzinga

May 5, 2021

11:41AM EDT Shares of eye care products company Alcon Inc. (ALC) are slipping 6 percent on Wednesday's trading despite the company turning to profit in the first quarter, helped by increased revenues. RTTNews

07:08AM EDT Alcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations Benzinga

May 4, 2021

05:25PM EDT Alcon Q1 Core EPS $0.49 Up From $0.45 YoY, Sales $1.91B Up From $1.82B YoY; Sees FY21 Core EPS $1.85-$1.95 vs $1.92 Estimate, Sales $7.8B-$8B vs $7.87B Est. Benzinga

04:30PM EDT Alcon Reports First Quarter 2021 Results Business Wire

Apr 28, 2021

05:20PM EDT Alcon To Buy US Commercialization Rights To Ophthalmic Eye Drop Simbrinza For $355M Benzinga

05:17PM EDT Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza Business Wire

11:30AM EDT Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting Business Wire

09:34AM EDT Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S. Benzinga

Mar 25, 2021

10:58AM EDT Where Alcon Stands With Analysts Benzinga

09:11AM EDT Jefferies Maintains Buy on Alcon, Raises Price Target to $85 Benzinga

Mar 24, 2021

06:59PM EDT Alcon Publishes Agenda for Annual General Meeting Business Wire

Mar 22, 2021

10:43AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2021 Benzinga

06:48AM EDT BTIG Upgrades Alcon to Buy, Announces $78 Price Target Benzinga

Mar 12, 2021

04:04PM EST Alcon to Host Virtual Capital Markets Day on March 24 Business Wire

Mar 1, 2021

11:00AM EST Alcon's Sue-Jean Lin Wins 2021 Dallas CIO of the Year Business Wire

Feb 26, 2021

07:00AM EST Algoma Central Corporation Reports Operating Results for the Year Ended December 31, 2020 Business Wire

Feb 25, 2021

08:40AM EST Morgan Stanley Maintains Overweight on Alcon, Raises Price Target to $79 Benzinga

07:46AM EST Credit Suisse Maintains Outperform on Alcon, Raises Price Target to $86 Benzinga

Feb 23, 2021

05:22PM EST Recap: Alcon Q4 Earnings Benzinga

04:37PM EST Alcon Q4 EPS $0.41, Inline, Sales $1.93B Beat $1.89B Estimate Benzinga

04:21PM EST Alcon Reports Fourth Quarter and Full Year 2020 Results Business Wire

04:09AM EST Earnings Scheduled For February 23, 2021 Benzinga

Feb 18, 2021

08:03AM EST Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S. Business Wire

Jan 20, 2021

01:13AM EST Alcon Launches PRECISION1 For Astigmatism Contact Lenses In The U.S. RTTNews

Jan 7, 2021

01:05AM EST Alcon Unveils AcrySof IQ Vivity, A Non-Diffractive Extended Depth Of Focus Intraocular Lens In The U.S. RTTNews

01:01AM EST Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S. Business Wire

Dec 15, 2020

11:15AM EST Morgan Stanley Maintains Overweight on Alcon, Raises Price Target to $75 Benzinga

Nov 13, 2020

08:35AM EST Credit Suisse Maintains Outperform on Alcon, Raises Price Target to $76 Benzinga

Nov 12, 2020

08:15AM EST 10 Biggest Price Target Changes For Thursday Benzinga

07:55AM EST Morgan Stanley Maintains Overweight on Alcon, Raises Price Target to $73 Benzinga

04:58AM EST SVB Leerink Maintains Market Perform on Alcon, Raises Price Target to $67 Benzinga

Nov 11, 2020

06:09AM EST A Peek Into The Markets: US Stock Futures Up; Crude Oil Surges 3% Benzinga

Nov 10, 2020

05:06PM EST Alcon: Q3 Earnings Insights Benzinga

04:59PM EST Alcon Q3 EPS $0.39 Beats $0.22 Estimate, Sales $1.82B Beat $1.67B Estimate Benzinga

04:30PM EST Alcon Reports Third Quarter 2020 Results Business Wire

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 9, 2020

08:30AM EST New Alcon Innovations in Intraocular Lenses, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meeting Business Wire

Nov 5, 2020

08:18AM EST Alcon Reports Data Presented Demonstrates PRECISION1 Rated Superior Over Leading Competitor Benzinga

08:00AM EST Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance Business Wire

Oct 8, 2020

08:00AM EDT Alcon Celebrates World Sight Day 2020 and Continues Commitment to Improving Worldwide Access to Eye Care Business Wire

Oct 6, 2020

08:15AM EDT Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practices Business Wire

Aug 27, 2020

12:32PM EDT Societe Generale Downgrades Alcon to Sell Benzinga

Aug 20, 2020

08:00AM EDT Alcon and Actress Katherine McNamara Encourage Consumers to See What Happens with PRECISION1(r) Contact Lenses Business Wire

04:39AM EDT SVB Leerink Maintains Market Perform on Alcon, Raises Price Target to $61 Benzinga

Aug 18, 2020

05:03PM EDT Alcon Q2 Sales $1.20B Beat $1.14B Estimate Benzinga

04:32PM EDT Alcon Q2 EPS $(0.21) Misses $(0.15) Estimate Benzinga

04:30PM EDT Alcon Reports Second Quarter 2020 Results Business Wire

04:02AM EDT Earnings Scheduled For August 18, 2020 Benzinga

Jul 21, 2020

09:00AM EDT Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye Business Wire

Jul 17, 2020

09:00AM EDT Alcon to Showcase Latest Innovations, Data at American Society of Retina Specialists 2020 Virtual Annual Meeting Business Wire

Jul 15, 2020

09:00AM EDT Alcon Issues First Corporate Responsibility Report as Independent Company Business Wire

Jul 14, 2020

07:57AM EDT Alcon Announces FDA Approval Of OTC Switch Of Pataday Once Daily Relief Extra Strength RTTNews

07:50AM EDT Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength Business Wire

.dark-mode .b8hZfm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .b8hZfm{ color: #333333; background-color: white; border: 2px solid #333333; }ALCAlcon Inc.stock NYSE

ALC
Alcon Inc.
stock NYSE